Results 21 to 30 of about 1,425,061 (397)

Differences in the performance of adjuvant chemotherapy between hemodialysis and nonhemodialysis patients

Cancer Medicine, 2023
Background The survival of hemodialysis (HD) patients with cancer is poor, which may be caused by undertreatment due to renal dysfunction. Particularly, adjuvant chemotherapy after surgery may be considered optional because of its preventive nature. This
Taisuke Ishii, Tomone Watanabe, Takahiro Higashi   +2 more
doaj   +1 more source

The role of adjuvant chemotherapy for patients with resected pancreatic cancer: Systematic review of randomized controlled trials and meta-analysis [PDF]

, 2007
Background: In patients undergoing surgery for resectable pancreatic cancer prognosis still remains poor. The role of adjuvant treatment strategies (including chemotherapy and chemoradiotherapy) following resection of pancreatic cancer remains ...
Bakkevold KE, Berger AC, Blackstock AW, Cress RD, Donna Pauler Ankerst, Gastrointestinal Tumour Study Group, Hochster HS, Kalser MH, Khanna A, Knaebel HP, Kosuge T, Luttges J, Oettle H, Ozols RF, Peto R, Regine WF, Stefan Boeck, Volker Heinemann   +17 more
core   +1 more source

Adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: updated results of the Seoul National university hospital experience

International Brazilian Journal of Urology, 2015
Objectives: The objective of this study was to update the long-term outcome in the treatment of locally advanced upper tract urothelial carcinoma (UTUC) after radical nephroureterectomy (RNU) regarding the role of adjuvant chemotherapy.
Hyung Suk Kim, Joong Sub Lee, Chang Wook Jeong, Cheol Kwak, Hyeon Hoe Kim, Ja Hyeon Ku   +5 more
doaj   +1 more source

Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment.

JAMA Oncology, 2020
Importance The benefit of adjuvant chemotherapy after resection of pancreatic cancer following neoadjuvant combination treatment with folinic acid, fluorouracil, irinotecan, and oxaliplatin (FOLFIRINOX) is unclear.
S. Roessel, E. Veldhuisen, S. Klompmaker, Q. Janssen, M. Hilal, A. Alseidi, A. Alseidi, A. Balduzzi, G. Balzano, C. Bassi, F. Berrevoet, M. Bonds, O. Busch, G. Butturini, M. Chiaro, K. Conlon, M. Falconi, I. Frigerio, G. Fusai, J. Gagnière, O. Griffin, T. Hackert, A. Halimi, U. Klaiber, K. Labori, G. Malleo, M. Marino, M. Mortensen, A. Nikov, M. Lesurtel, T. Keck, J. Kleeff, R. Pandé, P. Pfeiffer, D. Pietrasz, K. Roberts, A. S. Cunha, R. Salvia, O. Strobel, T. Tarvainen, P. Bossuyt, H. Laarhoven, J. Wilmink, B. Koerkamp, M. Besselink   +44 more
semanticscholar   +1 more source

Supplemental prophylactic intervention for chemotherapy-induced nausea and emesis (spice) trial: Protocol for a multi-centre double-blind placebo-controlled randomized trial [PDF]

, 2018
Aim: There is significant recent interest in the role of ginger root (Zingiber officinale) as an adjuvant therapy for chemotherapy‐induced nausea. The supplemental prophylactic intervention for chemotherapy‐induced nausea and emesis (SPICE) trial aims
Bird, Robert, Crichton, Megan, https://orcid.org/, Isenring, Elizabeth, Lohning, Anna E., Marshall, Skye, Marx, Wolfgang, McCarthy, Alexandra (Sandie), Molassiotis, Alex, Ried, Karin   +9 more
core   +1 more source

Adjuvant chemotherapy [PDF]

Cancer, 1978
In this brief presentation, an attempt was made to illustrate why it is not possible to carry over chemotherapeutic trial results from one animal cancer to another or one human cancer to another without corrections for differences in (a) staging, (b) dose response, and (c) tumor regrowth rates.
openaire   +2 more sources

Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial.

JAMA Oncology, 2020
Importance A high 21-gene recurrence score (RS) by breast cancer assay is prognostic for distant recurrence of early breast cancer after local therapy and endocrine therapy alone, and for chemotherapy benefit.
J. Sparano, R. Gray, D. Makower, K. Albain, T. Saphner, S. Badve, L. Wagner, V. Kaklamani, M. Keane, H. Gómez, P. Reddy, T. Goggins, I. Mayer, D. Toppmeyer, A. Brufsky, M. Goetz, J. Berenberg, Catalin Mahalcioiu, C. Desbiens, D. Hayes, E. Dees, C. Geyer, J. Olson, W. Wood, T. Lively, S. Paik, M. Ellis, J. Abrams, G. Sledge   +28 more
semanticscholar   +1 more source

Current Oncological Treatment of Patients with Pancreatic Cancer in Germany: Results from a National Survey on behalf of the Arbeitsgemeinschaft Internistische Onkologie and the Chirurgische Arbeitsgemeinschaft Onkologie of the Germany Cancer Society [PDF]

, 2009
Background: No data have previously been available regarding the current treatment of patients with pancreatic cancer (PC) in German hospitals and medical practices.
Boeck, Stefan, Bruns, Christiane J., Heinemann, Volker, Jauch, Karl-Walter, Sargent, Mirja, Schäfer, Claus, Seufferlein, Thomas   +6 more
core   +1 more source

Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer

BMC Gastroenterology, 2020
Background Biliary tract cancers (BTC) have a poor prognosis even after curative resection because of frequent local and distant recurrences. Therefore, the importance of adjuvant therapy in BTC has been advocated to improve outcomes. However, the choice
Hyera Kim, Mi Hwa Heo, Jin Young Kim
doaj   +1 more source

Variations in the body mass index in Brazilian women undergoing adjuvant chemotherapy for breast cancer [PDF]

Revista Brasileira de Ginecologia e Obstetrícia, 2014
PURPOSE:To evaluate variations in the body mass index in patients undergoing adjuvant chemotherapy for breast cancer, and to associate these changes with patient's age and adjuvant chemotherapy regimen.METHODS:We performed a retrospective cohort study in
Marcos Desídérío Ricci, Maria Carolina Formigoni, Lucia Maria Martins Zuliani, Denis Seiiti Aoki, Bruna Salani Mota, José Roberto Filassi, José Roberto Morales Piato, Edmund Chada Baracat   +7 more
doaj   +2 more sources